Literature DB >> 12885622

Theoretical modeling of prion disease incubation.

R V Kulkarni1, A Slepoy, R R P Singh, D L Cox, F Pázmándi.   

Abstract

We apply a theoretical aggregation model to laboratory and epidemiological prion disease incubation time data. In our model, slow growth of misfolded protein aggregates from small initial seeds controls the latent or lag phase; aggregate fissioning and subsequent spreading leads to an exponential growth phase. Our model accounts for the striking reproducibility of incubation times for high dose inoculation of lab animals. In particular, low dose yields broad incubation time distributions, and increasing dose narrows distributions and yields sharply defined onset times. We also explore how incubation time statistics depend upon aggregate morphology. We apply our model to fit the experimental dose-incubation curves for distinct strains of scrapie, and explain logarithmic variation at high dose and deviations from logarithmic behavior at low dose. We use this to make testable predictions for infectivity time-course experiments.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12885622      PMCID: PMC1303196          DOI: 10.1016/S0006-3495(03)74514-7

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  33 in total

1.  Designing drugs to stop the formation of prion aggregates and other amyloids.

Authors:  J Masel; V A Jansen
Journal:  Biophys Chem       Date:  2000-12-15       Impact factor: 2.352

Review 2.  Amyloid fibrillogenesis: themes and variations.

Authors:  J C Rochet; P T Lansbury
Journal:  Curr Opin Struct Biol       Date:  2000-02       Impact factor: 6.809

3.  Mapping the parameters of prion-induced neuropathology.

Authors:  M P Stumpf; D C Krakauer
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

Review 4.  Lipid rafts and signal transduction.

Authors:  K Simons; D Toomre
Journal:  Nat Rev Mol Cell Biol       Date:  2000-10       Impact factor: 94.444

Review 5.  Prion protein interconversions and the transmissible spongiform encephalopathies.

Authors:  M Horiuchi; B Caughey
Journal:  Structure       Date:  1999-10-15       Impact factor: 5.006

6.  Neurotoxicity but not infectivity of prion proteins can be induced reversibly in vitro.

Authors:  K Post; D R Brown; M Groschup; H A Kretzschmar; D Riesner
Journal:  Arch Virol Suppl       Date:  2000

7.  Scrapie infections initiated at varying doses: an analysis of 117 titration experiments.

Authors:  A R McLean; C J Bostock
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-08-29       Impact factor: 6.237

8.  Interactions between heterologous forms of prion protein: binding, inhibition of conversion, and species barriers.

Authors:  M Horiuchi; S A Priola; J Chabry; B Caughey
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

9.  Quantifying the kinetic parameters of prion replication.

Authors:  J Masel; V A Jansen; M A Nowak
Journal:  Biophys Chem       Date:  1999-03-29       Impact factor: 2.352

10.  Closely similar values obtained when the ME7 strain of scrapie agent was titrated in parallel by two individuals in separate laboratories using two sublines of C57BL mice.

Authors:  D M Taylor; I McConnell; C E Ferguson
Journal:  J Virol Methods       Date:  2000-04       Impact factor: 2.014

View more
  6 in total

1.  Simulations of oligomeric intermediates in prion diseases.

Authors:  David L Mobley; Daniel L Cox; Rajiv R P Singh; Rahul V Kulkarni; Alexander Slepoy
Journal:  Biophys J       Date:  2003-10       Impact factor: 4.033

2.  Contact-induced structure transformation in transmembrane prion propagation.

Authors:  D-M Ou; C-C Chen; C-M Chen
Journal:  Biophys J       Date:  2007-01-26       Impact factor: 4.033

3.  Correlation analysis for the incubation period of prion disease.

Authors:  Se-Eun Bae; Sunghoon Jung; Ha-Yeon Kim; Hyeon S Son
Journal:  Prion       Date:  2012-07-01       Impact factor: 3.931

4.  Prion disease: exponential growth requires membrane binding.

Authors:  Daniel L Cox; Rajiv R P Sing; Sichun Yang
Journal:  Biophys J       Date:  2006-03-31       Impact factor: 4.033

5.  Scaling analysis reveals the mechanism and rates of prion replication in vivo.

Authors:  Georg Meisl; Timothy Kurt; Itzel Condado-Morales; Cyrus Bett; Silvia Sorce; Mario Nuvolone; Thomas C T Michaels; Daniel Heinzer; Merve Avar; Samuel I A Cohen; Simone Hornemann; Adriano Aguzzi; Christopher M Dobson; Christina J Sigurdson; Tuomas P J Knowles
Journal:  Nat Struct Mol Biol       Date:  2021-03-25       Impact factor: 15.369

6.  Emergence of prions selectively resistant to combination drug therapy.

Authors:  Cassandra M Burke; Kenneth M K Mark; Judit Kun; Kathryn S Beauchemin; Surachai Supattapone
Journal:  PLoS Pathog       Date:  2020-05-18       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.